These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 25457161)
1. Comment on: Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years. Sarr MG Surg Obes Relat Dis; 2015; 11(3):590-1. PubMed ID: 25457161 [No Abstract] [Full Text] [Related]
2. Response to Letter to the Editor Re: Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years. Ward EK; Austin GL Surg Obes Relat Dis; 2015; 11(5):1190-1. PubMed ID: 26645494 [No Abstract] [Full Text] [Related]
3. Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years. Ward EK; Jensen-Otsu E; Schoen JA; Rothchild K; Mitchell B; Austin GL Surg Obes Relat Dis; 2015; 11(3):585-90. PubMed ID: 25553887 [TBL] [Abstract][Full Text] [Related]
4. Association of short-term proton pump inhibitor therapy with weight gain in patients older than 40 years with gastric ulcer. Huang HH; Chen HS; Chen CY Surg Obes Relat Dis; 2015; 11(5):1187-9. PubMed ID: 26645493 [No Abstract] [Full Text] [Related]
5. Moderating the Enthusiasm of Sleeve Gastrectomy: Up to Fifty Percent of Reflux Symptoms After Ten Years in a Consecutive Series of One Hundred Laparoscopic Sleeve Gastrectomies. Mandeville Y; Van Looveren R; Vancoillie PJ; Verbeke X; Vandendriessche K; Vuylsteke P; Pattyn P; Smet B Obes Surg; 2017 Jul; 27(7):1797-1803. PubMed ID: 28190216 [TBL] [Abstract][Full Text] [Related]
6. Roux-en-Y gastric bypass in a patient with morphea. Lomas S; Forgione P Surg Obes Relat Dis; 2013; 9(6):e89-90. PubMed ID: 22326279 [No Abstract] [Full Text] [Related]
7. Laparoscopic Roux-en-Y gastric bypass for treatment of symptomatic paraesophageal hernia in the morbidly obese: medium-term results. Chaudhry UI; Marr BM; Osayi SN; Mikami DJ; Needleman BJ; Melvin WS; Perry KA Surg Obes Relat Dis; 2014; 10(6):1063-7. PubMed ID: 24836818 [TBL] [Abstract][Full Text] [Related]
8. Varying marginal ulcer rates in patients undergoing laparoscopic Roux-en-Y gastric bypass for morbid obesity versus gastroesophageal reflux disease: is the acid pocket to blame? Gilmore MM; Kallies KJ; Mathiason MA; Kothari SN Surg Obes Relat Dis; 2013; 9(6):862-6. PubMed ID: 23522621 [TBL] [Abstract][Full Text] [Related]
17. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Roux-en-Y gastric bypass for severe gastroesophageal reflux after vertical banded gastroplasty. Bloomberg RD; Urbach DR Obes Surg; 2002 Jun; 12(3):408-11. PubMed ID: 12082898 [TBL] [Abstract][Full Text] [Related]
19. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study. Coblijn UK; Lagarde SM; de Castro SM; Kuiken SD; van Tets WF; van Wagensveld BA Surg Obes Relat Dis; 2016 Feb; 12(2):246-52. PubMed ID: 26381875 [TBL] [Abstract][Full Text] [Related]